CD133+ cells from the oral SCC cell line UPCI: SCC-016 were characterized to possess cancer stem-like properties of increased tumorigenicity, chemoresistance to paclitaxel, and greater sphere-forming ability than the CD133- population. Here, PROM1 is linked to cancer.